Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)
Who is this study for? Patients with Post-operative Pain
What treatments are being studied? Quadratus Lumborum Nerve Block
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult subjects undergoing elective primary total hip arthroplasty
Locations
United States
California
UCLA Medical Center, Santa Monica
RECRUITING
Santa Monica
Contact Information
Primary
Jennifer Scovotti, MA
jscovotti@mednet.ucla.edu
310-206-4484
Backup
Pamela Chia, MD
pchia@mednet.ucla.edu
310-267-83217
Time Frame
Start Date: 2022-03-29
Estimated Completion Date: 2027-01
Participants
Target number of participants: 80
Treatments
Active_comparator: Intervention Group
Quadratus lumborum nerve block with 0.25% ropivacaine
Placebo_comparator: Control Group
Quadratus lumborum nerve block with saline
Authors
Related Therapeutic Areas
Sponsors
Leads: University of California, Los Angeles